Out-licensing: Pharmaceutical/Generics & Infectious diseases

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Open Innovation for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Due Diligence; Comparison
Due Diligence: Overview; Top Applications; Online Panel Discussions; Request Consultation
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..6 of 6 - per page
Order by

New Active Ingredient + Innovative Drug Delivery System = Business Success More

A liquid system which enables rapid transmigration of therapeutic doses of up to large molecules More

Coupling drug substances with hydroxyethyl starch (HES) derivatives to improve pharmacokinetics and pharmacodynamics. More

Adjuvant that induces a potent antigen-specific CD8 cytotoxic T-cell response with long lasting immunity More

Proguanil & Chloroquine preparations More

A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More

Displaying 1..6 of 6 - per page
Order by

Therapeutic target: Bacteria or virus; Bioterrorism; Diseases; Hepatitis (other); Nosocomial infections; Parasitic diseases; Treatments
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.